View Older Stories View More Recent Stories

Jul 26, 2024 08:31AM NovaBay Pharma (NBY) Announces Pricing of $3.5 Million Underwritten Public Offering
Jul 26, 2024 08:30AM NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
Jul 23, 2024 08:30AM Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
Jul 19, 2024 08:31AM Biodexa Pharmaceuticals (BDRX) Prices $5 Million Registered Direct Offering and Concurrent Private Placement
Jul 19, 2024 08:30AM Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
Jul 16, 2024 07:11PM Trinity Capital Inc. Prices Offering of $100.0 Million of 7.875% Notes due 2029
Jul 16, 2024 06:00AM Kingswood U.S. Continues Expansion of Successful In-House Investment Banking Group with Appointment of Tony Tian as Senior Managing Director
Jul 15, 2024 09:00AM Osaic Launches Advanced Retirement Income Planning Platform
Jul 11, 2024 06:51AM NovaBay Pharma (NBY) Reports Prelim Q2 Revenue of $2.4M
Jul 11, 2024 06:50AM NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
Jul 9, 2024 04:05PM Saratoga Investment Corp. Announces Fiscal First Quarter 2025 Financial Results
Jul 3, 2024 06:39AM Ardelyx, Inc (ARDX) PT Lowered to $12.50 at Ladenburg Thalmann
Jun 27, 2024 06:29PM Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030
Jun 24, 2024 03:21PM Osaic Affiliate Welcomes Engler, Garrow & Roth, Ltd., and Hartmann•Bogan Financial Planning
Jun 20, 2024 08:37AM Sonnet BioTherapeutics (SONN) Receives $3.4M From Warrants Exercise
Jun 20, 2024 08:30AM Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
Jun 17, 2024 10:51PM UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
Jun 17, 2024 04:47PM UroGen Pharma (URGN) Commences Share and Warrant Offering
Jun 17, 2024 04:46PM UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
Jun 17, 2024 02:03PM Ladenburg Thalmann Downgrades Coeptis Therapeutics Holdings, Inc. (COEP) to Neutral
Jun 14, 2024 06:54AM UroGen Pharma (URGN) PT Raised to $53.50 at Ladenburg Thalmann
Jun 14, 2024 06:54AM Ladenburg Thalmann Starts Red Cat Holdings Inc. (RCAT) at Buy
Jun 12, 2024 06:52AM Ladenburg Thalmann Downgrades Entergy Corp (ETR) to Neutral
Jun 6, 2024 06:33AM Ladenburg Thalmann Upgrades American Electric Power (AEP) to Neutral
Jun 6, 2024 06:32AM Ladenburg Thalmann Upgrades Pinnacle West Capital (PNW) to Buy
May 31, 2024 08:51AM Calidi Biotherapeutics (CLDI) Exercises $2.1M of Warrants
May 31, 2024 08:51AM  Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
May 29, 2024 06:47AM Ladenburg Thalmann Reiterates Buy Rating on Palisade Bio Inc. (PALI)
May 22, 2024 08:30AM Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises
May 22, 2024 06:50AM BiomX (PHGE) PT Lowered to $2 at Ladenburg Thalmann
May 15, 2024 04:00PM NeuroMetrix Reports Q1 2024 Business Highlights
May 15, 2024 10:31AM Ladenburg Thalmann & Co. Inc. Elevates Executive Leadership with Co-CEO Appointments
May 14, 2024 06:46AM Capricor Therapeutics (CAPR) PT Raised to $25 at Ladenburg Thalmann
May 10, 2024 04:32PM Form 13F-NT LADENBURG THALMANN ASSET For: Mar 31
May 10, 2024 10:35AM SoundHound AI (SOUN) stock jumps on strong subscription demand in Q1
May 10, 2024 07:07AM Ladenburg Thalmann Downgrades Ready Capital Corp. (RC) to Neutral
May 7, 2024 07:30AM Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
May 6, 2024 04:05PM Saratoga Investment Corp. Announces Fiscal Year-End and Fourth Quarter 2024 Financial Results
May 6, 2024 01:50PM Osaic Completes Acquisition of Lincoln Wealth
May 2, 2024 08:33AM Palisade Bio Inc. (PALI) Announces $4 Million Private Placement of Common Stock, Warrants
May 2, 2024 08:30AM Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
May 2, 2024 06:34AM TG Therapeutics (TGTX) PT Raised to $40 at Ladenburg Thalmann
Apr 30, 2024 06:46AM Ladenburg Thalmann Starts Marker Therapeutics (MRKR) at Buy
Apr 29, 2024 07:26AM Alliant Energy (LNT) PT Lowered to $48 at Ladenburg Thalmann
Apr 26, 2024 08:31AM Biodexa Pharmaceuticals (BDRX) Enters Exclusive License to eRapa
Apr 26, 2024 08:30AM Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
Apr 26, 2024 08:30AM Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
Apr 26, 2024 06:33AM Ladenburg Thalmann Starts Spire (SR) at Neutral
Apr 19, 2024 05:22PM Gryphon Digital Mining (GRYP) Enters $70M ATM Agreement
Apr 19, 2024 04:05PM Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
View More Recent Stories View Older Stories